Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Utility of the Sindbis replicon system as an Env-targeted HIV vaccine.

Center RJ, Miller A, Wheatley AK, Campbell SM, Siebentritt C, Purcell DF.

Vaccine. 2013 Apr 26;31(18):2260-6. doi: 10.1016/j.vaccine.2013.02.064. Epub 2013 Mar 13.

PMID:
23499600
[PubMed - indexed for MEDLINE]
2.

Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.

Barnett SW, Burke B, Sun Y, Kan E, Legg H, Lian Y, Bost K, Zhou F, Goodsell A, Zur Megede J, Polo J, Donnelly J, Ulmer J, Otten GR, Miller CJ, Vajdy M, Srivastava IK.

J Virol. 2010 Jun;84(12):5975-85. doi: 10.1128/JVI.02533-09. Epub 2010 Apr 14.

PMID:
20392857
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.

Perri S, Greer CE, Thudium K, Doe B, Legg H, Liu H, Romero RE, Tang Z, Bin Q, Dubensky TW Jr, Vajdy M, Otten GR, Polo JM.

J Virol. 2003 Oct;77(19):10394-403.

PMID:
12970424
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.

Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, Weiner DB, Moss B, Kim JH, Birx D, VanCott TC.

Vaccine. 2012 Feb 27;30(10):1830-40. doi: 10.1016/j.vaccine.2011.12.131. Epub 2012 Jan 9.

PMID:
22234262
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.

Domm W, Brooks L, Chung HL, Feng C, Bowers WJ, Watson G, McGrath JL, Dewhurst S.

Vaccine. 2011 Sep 16;29(40):7080-9. doi: 10.1016/j.vaccine.2011.07.008. Epub 2011 Jul 27.

PMID:
21801777
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.

Zhang X, Sobue T, Isshiki M, Makino S, Inoue M, Kato K, Shioda T, Ohashi T, Sato H, Komano J, Hanabusa H, Shida H.

PLoS One. 2012;7(12):e51633. doi: 10.1371/journal.pone.0051633. Epub 2012 Dec 7.

PMID:
23236521
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.

Vajdy M, Gardner J, Neidleman J, Cuadra L, Greer C, Perri S, O'Hagan D, Polo JM.

J Infect Dis. 2001 Dec 15;184(12):1613-6. Epub 2001 Dec 3.

PMID:
11740739
[PubMed - indexed for MEDLINE]
Free Article
8.

Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.

Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K.

Clin Immunol. 2006 Apr;119(1):32-7. Epub 2006 Feb 2.

PMID:
16458074
[PubMed - indexed for MEDLINE]
9.

Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.

Mörner A, Douagi I, Forsell MN, Sundling C, Dosenovic P, O'Dell S, Dey B, Kwong PD, Voss G, Thorstensson R, Mascola JR, Wyatt RT, Karlsson Hedestam GB.

J Virol. 2009 Jan;83(2):540-51. doi: 10.1128/JVI.01102-08. Epub 2008 Nov 12.

PMID:
19004960
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.

McBurney SP, Ross TM.

Vaccine. 2009 Jul 9;27(32):4337-49. doi: 10.1016/j.vaccine.2009.04.032. Epub 2009 May 3.

PMID:
19389453
[PubMed - indexed for MEDLINE]
11.

HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.

Yang L, Song Y, Li X, Huang X, Liu J, Ding H, Zhu P, Zhou P.

J Virol. 2012 Jul;86(14):7662-76. doi: 10.1128/JVI.07164-11. Epub 2012 May 2.

PMID:
22553333
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice.

Bruce CB, Akrigg A, Sharpe SA, Hanke T, Wilkinson GW, Cranage MP.

J Gen Virol. 1999 Oct;80 ( Pt 10):2621-8.

PMID:
10573155
[PubMed - indexed for MEDLINE]
Free Article
13.

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin BA, Pensiero M, Butler C, Moss B, Robinson HL; HVTN 205 Study Group; National Institutes of Allergy and Infectious Diseases HIV Vaccines Trials Network.

J Infect Dis. 2014 Jul 1;210(1):99-110. doi: 10.1093/infdis/jiu003. Epub 2014 Jan 7.

PMID:
24403557
[PubMed - indexed for MEDLINE]
14.

A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.

Buffa V, Negri DR, Leone P, Bona R, Borghi M, Bacigalupo I, Carlei D, Sgadari C, Ensoli B, Cara A.

J Gen Virol. 2006 Jun;87(Pt 6):1625-34.

PMID:
16690927
[PubMed - indexed for MEDLINE]
Free Article
15.

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.

Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.

Virus Res. 2006 Mar;116(1-2):11-20. Epub 2005 Oct 7.

PMID:
16214252
[PubMed - indexed for MEDLINE]
16.

Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.

Zhu W, Fu J, Lu J, Deng Y, Wang H, Wei Y, Deng L, Tan W, Liang G.

Arch Virol. 2013 May;158(5):1013-9. doi: 10.1007/s00705-012-1564-8. Epub 2012 Dec 19.

PMID:
23250650
[PubMed - indexed for MEDLINE]
17.

Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.

Tan GS, McKenna PM, Koser ML, McLinden R, Kim JH, McGettigan JP, Schnell MJ.

Virology. 2005 Jan 5;331(1):82-93.

PMID:
15582655
[PubMed - indexed for MEDLINE]
Free Article
19.

Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein.

Xu R, Srivastava IK, Greer CE, Zarkikh I, Kraft Z, Kuller L, Polo JM, Barnett SW, Stamatatos L.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):1022-30.

PMID:
17067273
[PubMed - indexed for MEDLINE]
20.

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.

Visciano ML, Diomede L, Tagliamonte M, Tornesello ML, Asti V, Bomsel M, Buonaguro FM, Lopalco L, Buonaguro L.

Vaccine. 2011 Jul 12;29(31):4903-12. doi: 10.1016/j.vaccine.2011.05.005. Epub 2011 May 17.

PMID:
21596074
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk